Local therapy for cytomegalovirus retinitis

Annals of Pharmacotherapy

Volumn 32, Issue 2, 1998, Pages 248-255

  Smith, Curtis L ^a,b  

^a FERRIS STATE UNIVERSITY   (United States)

^b MI   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cidofovir; Cytomegalovirus; Foscarnet; Ganciclovir; Intraocular

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ARTICLE; CATHETER INFECTION; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; ENDOPHTHALMITIS; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPLANT; INTRAVITREAL DRUG ADMINISTRATION; IRITIS; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RETINA DETACHMENT; RETINITIS; THROMBOCYTOPENIA;

ADMINISTRATION, TOPICAL; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; CYTOSINE; FOSCARNET; GANCICLOVIR; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; VITREOUS BODY;

EID: 0031940643     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17200     Document Type: Article

References (38)

1. Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR. et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol 1996;114:821-7.
2. McKenzie R, Travis WD, Dolan SA, Pittaluga S, Feuerstein IM, Shelhamer J, et al. The causes of death in patients with human immunodeficiency virus infection: a clinical and pathologic study with emphasis on the role of pulmonary diseases. Medicine 1991;70:326-43.
3. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med 1993;329:1922-6.
4. Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol 1987;103:17-23.
5. Büchi ER, Fitting PL, Michel AE. Long-term intravitreal ganciclovir for cytomegalovirus retinitis in a patient with AIDS. Arch Ophthalmol 1988;106:1349-450.
6. Harris ML, Mathalone MBR. Intravitreal ganciclovir in CMV retinitis: case report. Br J Ophthalmol 1989;73:382-4.
7. Ussery FM, Gibson SR, Conklin RH, Piot DF, Stool EW, Conklin J. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis. Ophthalmology 1988;95:640-8.
8. Heinemann MH. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 1989;107:1767-72.
9. Cantrill HL, Henry K, Melroe NH, Knobloch WH, Ramsay RC, Balfour HH. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Ophthalmology 1989;96:367-74.
10. Cochereau-Massin I, Lehoang P, Lautier-Frau M, Zazoun L, Marcel P, Robinet M, et al. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1991;98:1348-55.
11. Montero MC, Pastor M, Buenestado C, Lluch A, Atienza M. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS. Ann Pharmacother 1996;30:717-23.
12. Hodge WG, Lalonde RG, Sampalis J, Deschenes J. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome. J Infect Dis 1996;174:393-6.
13. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992;326:213-20.
14. Young SH, Morlet N, Henry S, Hollows FC, Coronco MT. High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis. Med J Aust 1992;157:370-3.
15. Daikos GL, Pulido J, Kathpalia SB, Jackson GG. Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression. Br J Ophthalmol 1988;72:521-4.
16. Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol 1993;111:223-7.
17. Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994;112:1531-9.
18. Marx JL, Kapusta MA, Patel SS, LaBree LD, Walonker F, Rao NA, et al. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis. Arch Ophthalmol 1996;114:815-20.
19. Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann BD, Ganciclovir Implant Study Group. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med 1997;337:83-90.
20. Sanborn GE, Anand R, Torti RE, Nightingale SD, Cal SX, Yates B, et al. Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Arch Ophthalmol 1992;110:188-95.
21. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, 4: visual outcomes. Ophthalmology 1994; 101:1250-61.
22. Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1997;126:257-63.
23. Díaz-Llopis M, Chipont E, Sanchez S, España E, Navea A, Menezo JL. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1992;114:742-7.
24. Lieberman RM, Orellana J, Melton RC. Efficacy of intravitreal foscarnet in a patient with AIDS. N Engl J Med 1994;330:868-9.
25. Diaz-Llopis M, España E, Muñoz G, Navea A, Chipont E, Cano J, et al. High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 1994;78:120-4.
26. Package insert. Vistide (cidofovir). Foster City, CA: Gilead Sciences, September 1996.
27. Kirsch LS, Arevalo JF, DeClercq E, Chavez de la Paz E, Munguia D, Garcia R, et al. Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1995;119:466-76.
28. Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, DeClercq E, Freeman WR. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1995;102:533-43.
29. Taskintuna I, Rahhal FM, Arevalo JF, Munguia D, Banker AS, DeClercq E, et al. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1997;104:1049-57.
30. Rahhal FM, Arevalo JF, Munguia D, Taskintuna I, Chavez de la Paz E, Azen SP, et al. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Ophthalmology 1996;103:1078-83.
31. Kuppermann B, Wolitz R, Stagg R, Holland G, Palestine A, Flynn T, et al. A Phase II randomized, double-masked study of intraocular cidofovir for relapsing cytomegalovirus retinitis in patients with AIDS (abstract). In: Program and abstracts of the Vitreous Society Annual Meeting. Cancun, Mexico, December 8-12, 1996.
32. Spector SA. Cytomegalovirus: advanced in pathogenesis and improved approaches for treatment and prevention (abstract). In: Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 22-26, 1997:210.
33. Lieberman RM, Orellana J. Safety and efficacy of fomivirsen sodium (ISIS 2922) for CMV retinitis in AIDS patients (abstract). In: Abstracts of the Fourth Conference on Retroviruses and Opportunistic Infections. Washington, DC, January 22-26, 1997:121.
34. Kuppermann BD, Quiceno JI, Flores-Aguilar M, Connor JD, Capparelli EV, Sherwood CH, et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis 1993;168:1506-9.
35. Arevalo JF, Gonzalez C, Capparelli EV, Kirsch LS, Garcia RF, Quiceno JI, et al. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995;172:951-6.
36. Morlet N, Young S, Naidoo D, Graham G, Coroneo MT. High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration. Br J Ophthalmol 1996;80:214-6.
37. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Arch Intern Med 1995;155:65-74.
38. Drug topics red book. Montvale, NJ: Medical Economics Data, Inc., 1997.